Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study-Reference-Cited by-同舟云学术

Trastuzumab-Related Cardiotoxicity in Early Breast Cancer: A Cohort Study

Published:2013-07-01 Issue:7 Volume:18 Page:795-801
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Bonifazi Martina¹,Franchi Matteo¹,Rossi Marta¹²,Moja Lorenzo³⁴,Zambelli Alberto⁵,Zambon Antonella⁶,Corrao Giovanni⁶,La Vecchia Carlo¹²,Zocchetti Carlo⁷,Negri Eva¹

Affiliation:

1. Department of Epidemiology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCSS), Milan, Italy;

2. Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy;

3. Department of Biomedical Sciences for Public Health, University of Milan, Milan, Italy;

4. Unit of Clinical Epidemiology, Galeazzi Orthopedic Institute, IRCCS, Milan, Italy;

5. Medical Oncology Unit, S. Maugeri Foundation, IRCCS, Pavia, Italy;

6. Unit of Biostatistics and Epidemiology, Department of Statistics, University of Milano-Bicocca, Milan, Italy;

7. Operative Unit of Territorial Health Service, Health Directorate, Regione Lombardia, Milan, Italy

Abstract

Learning Objectives Evaluate the frequency of trastuzumab-related serious cardiac events in clinical practice. Assess the cumulative incidence of cardiac disorders at 1, 2, and 3 years after first administration, irrespective of drug discontinuation. Identify predictors for the onset of cardiotoxicity.

Funder

Programma Straordinario Oncologia—Ministero della Salute

Fondazione Umberto Veronesi

Italian Association for Cancer Research

Italian Foundation for Cancer Research

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://pericles-gcp.literatumonline.com/doi/pdf/10.1634/theoncologist.2013-0065

Reference29 articles.